AGENT TRADE NAME
Abacavir
Abiraterone
Ado-trastuzumabemtansine
Afatinib
Aldesleukin (rIL-2) Proleukin
Alemtuzumab Campath
Alitretinoin Panretin
Altretamine Hexalen
Aminoglutethimide
Amsacrine
Anastrozole Arimidex
Apomorphine
Arsenic Trioxide* Trisenox
Asparaginase/L-Asparaginase Elspar
Axitinib
Azacytidine Azacytidine
Azathioprime Azathioprine
Bexarotene Targretin
Bicalutamide Casodex
Belinostat
Bleomycin/Bleomycin Sulfate Blenoxane
Bosutinib
Brentuximabvedotin
Busulfan Myleran
Cabazitaxel
Capecitabine Xeloda
Carboplatin Paraplatin
Cabozantinib
Carfilzomib
Carmustine (BCNU) BiCNU
CCNU Belustine
Clomiphene*
Chlorambucil* Leukeran
Chloramphenicol
Chlornaphazin
Chlorotrianisene
Chlorozotocin
Cisplatin/Cis-Platin Platinol
Cladribine (2-chlorode-oxyadenosine, 2CdA) Leustatin
Crizotinib
Cyclophosphamide* Cytoxan, Neosar
Cyclosporin
Cytarabine (ara-C)/Cytosine Arabinoside Cytosar-U
Dabrafenib
Dacarbazine DTIC, DIC, DTIC-Dome
Dactinomycin (Actinomycin-D) Cosmegen
Daunomycin*
Daunorubicin/Daunorubicin Hydrochloride Cerubidine
Daunorubicin (Liposomal) DaunoXome
Deferiprone
Denileukin Diftitox Ontak
Dexrazoxane
Diethylstilbesterol
Docetaxel Taxotere
Doxorubicin Adriamycin
Doxorubicin Hydrochloride Liposomal Injection Doxil
Epinephrin (excluding Epinephrin salts)*
Epirubicin/Epirubicin Hydrochloride Ellence
Eribulin
Erlotinib
Eslicarbazepine
Estradiol
Estramustine Emcyt
Ethinyl Estradiol
Etoposide (VP-16-213) VePesid
Exemestane Aromasin
Enzalutamide
Fingolimod
Floxuridine
Fluconazole
Fludarabine/Fludarabine Phosphate Fludara
Fluorouracil/5-Fluorouracil Adrucil
Flutamide Eulexin
Fosphenytoin
Fulvestrant
Ganciclovir
Gemcitabine Gemzar
Gemtuzumab Ozogamicin Mylotarg
Goserelin/Goserelin Acetate Zoladex
Histrelin
Hydroxyurea Droxia, Mylocel
Ibritumomab Tiuetan Zevalin
Icatibant
Idarubicin Idamycin
Ifosfamide Ifex
Imatinib Mesylate Gleevec
Interferon-A/Interferon Alfa (2a, 2b) Roferon-A, Intron-A
Interleukin-2 (IL-2)
Irinotecan (CPT-11) Camposar
Isotretrinoin
Ixazomib
Letrozole Femara
Leuprolide/Leuprolide Acetate Lupron, Lupron Depot
Levamisole Ergamisol
Liraglutide Recombinant
Lomitapide
Lomustine (CCNU) CeeNu
Macitentan
Mechlorethamine (Nitrogen Mustard) Mustargen
Mechlorethamine Hydrochloride
Medroxyprogesterone/Medroxyprogesterone Acetate Provera
Megestrol/Megestrol Acetate Megace
Melphalan* Alkeran
Mercaptopurine (6-MP) Purinethol
Methimazole
Methotrexate (MTX) Mexate, Folex
Methyl-CCNU Semustine
Mipomersen
Misoprostol
Mithramycin Mithracin
Mitomycin
Mitomycin C* Mutamycin
Mitotane
Mitoxantrone Novantrone
Myleran
Nafarelin
Nevirapine
Nicotine*
Nilutamide NIlandron
Nitrogen Mustard Mustargen
Nitroglycerin*
Oprelvekin Neumega
Ospemifene
Oxaliplatin Paclitaxel Taxol
Pamidronate
Panobinostat
Paliperidone
Pasireotide
Pegaspargase
Peginesatide
Pentostatin (2-deoxycoformycin, DCF) Nipent
Pertuzumab
Phentermine*
Phenytoin
Physostigmine*
Physostigmine salicylate*
Pipobroman
Plicamycin
Pomalidomide
Ponatinib
Procarbazine/Procarbazine Hydrochloride Matulane
Propylthiouracil
Regorafenib
Ribavirin
Riociguat
Rituximab Rituxan
Spironolactone
Streptozocin (Streptozoticin)* Zanosar
Temazepam
Tamoxifen/Tamoxifen Citrate Nolvadex
Temozolomide Temodar
Teniposide Vumon
Teosulfan
Testolactone
Thioguanine
Thiotepa Thioplex
Topiramate
Topotecan Hycamtin
Toremifene/Toremifene Citrate Fareston
Trametinib
Trastuzumab Herceptin
Teriflunmide
Tretinoin (ATRA) Vesanoid
Triethylene Thiophosphoramide Thiotepa
Trifluridine/tipiracil (combination only)
Triptorelin Pamoate Trelstar Depot
Tofacitinib
Ulipristal
Uracil Mustard* Uramustine
Valrubicin
Vandetanib
Vemurafenib
Vidarabine
Vinblastine/Vinblastine Sulfate Velban
Vincristine/Vincristine Sulfate Oncovin
Vindesine
Vinorelbine/Vinorelbine Tartrate Navelbine
VM-26
Voriconazole
Vismodegib
Warfarin*
Zidovudine Retrovir
Ziv-aflibercetp
*These agents are listed by the Environmental Protection Agency as hazardous wastes and must be disposed of as such
Sources: American Hospital Formulary Service Drug Information 1995
American Hospital Formulary Service Drug Information 2002
Occupational Safety and Health Administration (OSHA) Instruction PUB 8-1.1 Appendix A, Work Practice Guidelines for Personnel Dealing with Cytotoxic (Antineoplastic) Drugs, January 29, 1986
OSHA Instruction CPL 2-2.20B CH-4, Chapter 21, Controlling Occupational Exposure to Hazardous Drugs, April 14, 1995
OSHA Technical Manual Section VI, Chapter 2 Appendix VI:2-1, Some Common Drugs that are Considered Hazardous
Environmental Protection Agency Regulation 40 CFR 261.33
Oklahoma Department of Environmental Quality Instructions for Disposal of Antineoplastic (Chemotherapy) Agents at Permitted Biomedical Waste Incinerators
Adams, Val R., “Guide to Cancer Chemotherapeutic Regimens,” Pharmacy Practice News, October 2002 Supplement, pp. 29-46.
Adams, Val R., “Guide for the Administration and Use of Cancer Chemotherapeutic Agents 2003,” Oncology Special Edition, Vol 6, 2003, pp. 123-138.
Department of Health and Human Services, CDC, NIOSH. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014.
